newsfilter
← Latest News
GlobeNewswire·

Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement

FLORHAM PARK, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced that it received written